HealthPreparations

"TRAKLIR" (bosentan): price, analogues. Where to buy Trakley

"Traklir" (bosentan) belongs to the group of vasodilating (vasodilator) drugs. Their use creates the effect of expansion in the blood vessels, thanks to the relaxation of the muscular layer of the walls of the latter. And this allows, in turn, to improve the efficiency of organs, as their supply of oxygen from the incoming blood improves.

Next, your attention will be offered a description of the drug "Trakliir", the price of this product, as well as beneficial proposals for its acquisition.

Where it is better to buy "Trakliir": the price

Buy Drugs for treatment Patients often suffer from chronic illnesses. This is exacerbated by the fact that such a person, as a rule, does not have the opportunity to earn money for their purchase. After all, the patient has a reduced capacity for work, or even is disabled at all. The famous Indian company Cipla Ltd. Produces a generic of the described agent - Bosentas, which has the same active substance, and hence the same therapeutic effect.

On the "Trakliir" the price in Russia is kept within 200 000 rubles, and on the site WWW.ONKO24.COM its generic you can buy almost 10 times cheaper . You will only need to present a document confirming the need for such treatment.

The low cost of tablets is due only to the fact that their manufacturer does not need to spend money on the development, verification and promotion of medicines on the market. The quality of it remains high. In this case, cheap does not mean bad.

Indications

This agent is available in the form of tablets. It is prescribed to patients (adults and children from 3 years and older) in certain pathologies:

  • With primary (hereditary or idiopathic) pulmonary arterial hypertension (PAH), to improve clinical manifestations in patients with diagnosed II-IV functional class of the disease and to improve the tolerance of physical exertion;
  • With secondary pulmonary arterial hypertension (PAH), taking place against the background of systemic scleroderma;
  • With PAH, which arose as a result of heart disease with a violation of hemodynamics.

"Traklir" is also prescribed for systemic scleroderma and progression of ulcerative lesions of the upper or lower extremities, to reduce the number of new ulcers.

Dosage

These tablets are taken twice a day, not correlating it with the intake of food, in the morning and in the evening. At the initial stage, the appointment of the drug and monitoring of therapy should be carried out only under the supervision of an experienced specialist.

The dose of the drug "Trakliir", as a rule, is 62.5 mg in the first 4 weeks of treatment, and then it is increased to 125 mg. In some patients, a dosage increase of up to 250 mg is possible.

The drug is given to children depending on the body weight.

Contraindications

"Trakliir" is not assigned:

  • Children up to 3 years;
  • Pregnant;
  • Nursing;
  • Suffering from severe arterial hypotension;
  • Moderate and severe liver function;
  • Having a hypersensitivity to the components of the drug.

Care should be taken in patients with mild liver function disorder.

Special instructions for the use of the drug "Trakliir": instruction

In the process of therapy, it is necessary to monitor once a month the activity of hepatic transaminases. At regular increases in the dose of the drug after 2 weeks, the activity of these enzymes should also be checked.

In the case of manifestations of associated clinical symptoms of liver disorders (nausea, abdominal pain, apathy, severe fatigue, jaundice), treatment with Traclyr should be discontinued.

Instruction to the said facility, in addition, suggests before the treatment to examine women of reproductive age for the absence of pregnancy. And in the course of therapy and within 3 months after it they should use reliable contraceptives. Since the use of the described drug reduces the effectiveness of hormonal contraceptives, patients should use additional methods to prevent pregnancy.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 en.unansea.com. Theme powered by WordPress.